Cargando…

Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice

Amphotericin B deoxycholate (AmB), a classic antifungal drug, remains the initial treatment of choice for deep fungal infections, but it is not appropriate for treatment of cryptococcal meningitis due to its inability to pass through the blood–brain barrier (BBB). We examined the efficacy of amphote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Nan, Gu, Julin, Zhu, Yuanjie, Wen, Hai, Ren, Qiushi, Chen, Jianghan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124396/ https://www.ncbi.nlm.nih.gov/pubmed/21720503 http://dx.doi.org/10.2147/IJN.S17503

Ejemplares similares

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
por: Jarvis, Joseph N, et al.
Publicado: (2022)

Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles
por: Tian, Xin-Hua, et al.
Publicado: (2011)

Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved Properties as an Anticancer Agent
por: Alavi, Seyed Ebrahim, et al.
Publicado: (2019)

Paradoxical respiratory failure due to cryptococcal pneumonia after amphotericin B treatment for HIV-associated cryptococcal meningitis
por: Scriven, James E., et al.
Publicado: (2018)

A Novel Cryptococcal Meningitis Therapy: The Combination of Amphotericin B and Posaconazole Promotes the Distribution of Amphotericin B in the Brain Tissue
por: Yang, Ming, et al.
Publicado: (2020)

Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis
por: Lestner, Jodi, et al.
Publicado: (2017)

An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis
por: Ngan, Nguyen Thi Thuy, et al.
Publicado: (2021)

The Effect of Polybutylcyanoacrylate Nanoparticles as a Protos Delivery Vehicle on Dental Bone Formation
por: Chang, Li-Ching, et al.
Publicado: (2021)

Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
por: Bicanic, Tihana, et al.
Publicado: (2015)

A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.
por: Ngan, Nguyen Thi Thuy, et al.
Publicado: (2019)

Case report: Reversible encephalopathy associated with liposomal amphotericin B in a patient with cryptococcal meningitis
por: Luo, Si, et al.
Publicado: (2022)

869. Oral Encochleated Amphotericin B for Cryptococcal Meningitis: a Phase II Randomized Trial
por: Atukunda, Mucunguzi, et al.
Publicado: (2022)

Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal Meningitis
por: Rolfes, Melissa A., et al.
Publicado: (2015)

Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis
por: Stott, Katharine E., et al.
Publicado: (2018)

Microglia are not protective against cryptococcal meningitis
por: Mohamed, Sally H., et al.
Publicado: (2023)

Preparation, Characterization, and Evaluation of Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved In Vitro and In Vivo Anticancer Activities
por: Ghaferi, Mohsen, et al.
Publicado: (2020)

Short-Course Induction Treatment with Intrathecal Amphotericin B Lipid Emulsion for HIV Infected Patients with Cryptococcal Meningitis
por: Alvarez-Uria, Gerardo, et al.
Publicado: (2015)

Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis
por: Lu, R., et al.
Publicado: (2019)

Venous Sinus Dysplasia Masking the Diagnosis of Cryptococcal Meningitis
por: Zheng, Qian, et al.
Publicado: (2016)

Standardized Electrolyte Supplementation and Fluid Management Improves Survival During Amphotericin Therapy for Cryptococcal Meningitis in Resource-Limited Settings
por: Bahr, Nathan C., et al.
Publicado: (2014)

Comparison between Polybutylcyanoacrylate Nanoparticles with Either Surface-Adsorbed or Encapsulated Brain-Derived Neurotrophic Factor on the Neural Differentiation of iPSCs
por: Lin, Martin Hsiu-Chu, et al.
Publicado: (2019)

Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa
por: Meiring, Susan, et al.
Publicado: (2016)

Molecular mechanisms of cryptococcal meningitis
por: Liu, Tong-Bao, et al.
Publicado: (2012)

Cryptococcal meningitis complicating sarcoidosis
por: Leonhard, Sonja E., et al.
Publicado: (2016)

Characterization and Optimization of Chitosan-Coated Polybutylcyanoacrylate Nanoparticles for the Transfection-Guided Neural Differentiation of Mouse Induced Pluripotent Stem Cells
por: Lin, Martin Hsiu-Chu, et al.
Publicado: (2021)

High Mortality in HIV-Associated Cryptococcal Meningitis Patients Treated With Amphotericin B–Based Therapy Under Routine Care Conditions in Africa
por: Patel, Raju K K, et al.
Publicado: (2018)

Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort study
por: Ahimbisibwe, Cynthia, et al.
Publicado: (2019)

Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study
por: Liu, Junyu, et al.
Publicado: (2022)

Efficacy of APX2039 in a Rabbit Model of Cryptococcal Meningitis
por: Giamberardino, Charles D., et al.
Publicado: (2022)

Short-Course Rather Than Low-Dose Amphotericin B May Exert Potential Influence on Mortality in Cryptococcal Meningitis Patients Treated With Amphotericin B Plus Flucytosine Alone or in Combination With Fluconazole
por: Xu, Lijun, et al.
Publicado: (2019)

1331. High direct costs caused by Cryptococcal meningitis treated with Amphotericin B deoxycholate in a public hospital in Lima, Peru. 2021-2022
por: Vilcarromero, Stalin, et al.
Publicado: (2023)

Cryptococcal meningitis: epidemiology and therapeutic options
por: Sloan, Derek J, et al.
Publicado: (2014)

Hearing Loss in Cryptococcal Meningitis Survivors
por: Lofgren, Sarah, et al.
Publicado: (2017)

Treatment for HIV‐associated cryptococcal meningitis
por: Tenforde, Mark W, et al.
Publicado: (2018)

Cryptococcal meningitis: A neglected NTD?
por: Molloy, Síle F., et al.
Publicado: (2017)

Cryptococcal Meningitis in an Apparent Immunocompetent Patient
por: Poley, Marian, et al.
Publicado: (2019)

Cryptococcal Meningitis in an Apparent Immunocompetent Host
por: Molina, Guarina, et al.
Publicado: (2023)

Connecting Cryptococcal Meningitis and Gut Microbiome
por: Ma, Yuanyuan, et al.
Publicado: (2023)

Efficacy of Oral APX001 in a Murine Model of Cryptococcal Meningitis
por: Schell, Wiley A, et al.
Publicado: (2017)

Analysis of the efficacy and related factors of ventriculoperitoneal shunt for AIDS with cryptococcal meningitis
por: Chai, Zhaohui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oup47haqugj6l7s1p2ft945c5g